Sale of JoCo pharmaceutical provider brings a side effect: litigation over the deal
The formers owners of RegaloRx filed a lawsuit claiming they haven't been fully compensated by the company's new owner AlphaScrip, which in turn claims fraudulent inducement to enter the 2023 sale agreement.